Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China flag China · Delayed Price · Currency is CNY
16.80
-0.49 (-2.83%)
Nov 17, 2026, 3:00 PM CST

Aurisco Pharmaceutical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6741,6971,4761,2631,008803.36
Revenue Growth
3.07%15.02%16.89%25.24%25.48%11.36%
Gross Profit
898.21,000844.36698.32512.57394.72
Operating Income
418.56532.56386.4278.83208.21182.76
Net Income
316.53449.21354.79289.42210.96168.71
Earnings Per Share
0.771.100.890.710.520.42
EPS Growth
-27.44%23.60%25.35%36.54%23.81%0%

Revenue by Segment

Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Sales of active pharmaceutical ingredients and Intermediates
1,4681,141
Sale of Drug Product
184.4220.02
Trading of active pharmaceutical ingredients and intermediates
36111.39
Others
8.733.67
Total
1,6971,476

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
601.36953.91,069545.84391.74444.61
Total Debt
973.38976.34947.85116.8852.6917.97
Net Cash (Debt)
-372.01-22.45121.42428.95339.05426.64
Net Cash Growth
---71.69%26.52%-20.53%-24.37%
Net Cash Per Share
-0.91-0.050.301.050.841.06

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
398.64421.5332.41385.61166.41201.57
Capital Expenditures
-366.73-350.07-540.28-305.48-216.23-250.61
Free Cash Flow
31.9271.42-207.8780.13-49.82-49.04
Free Cash Flow Growth
-17.84%-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.64%58.92%57.22%55.31%50.85%49.13%
Operating Margin
25.00%31.37%26.18%22.09%20.65%22.75%
Pretax Margin
22.04%30.53%27.61%26.07%23.88%23.90%
Profit Margin
18.90%26.46%24.04%22.92%20.93%21.00%
FCF Margin
1.91%4.21%-14.09%6.35%-4.94%-6.11%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3400.3400.2900.2200.1600.130
Dividend Per Share Growth
17.24%17.24%31.82%37.50%23.08%8.33%
Dividend Yield
2.02%1.36%1.37%0.85%0.65%0.59%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.7822.6524.1836.2447.5452.34
Forward PE
-20.2018.6930.4739.8244.04
P/FCF Ratio
214.24142.46-130.89--
PS Ratio
4.085.995.818.319.9510.99